New Zealand markets closed

PFE Jun 2023 55.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
2.43000.0000 (0.00%)
As of 03:51PM EDT. Market open.
Full screen
Previous close2.4300
Open2.2000
Bid0.0000
Ask0.0000
Strike55.00
Expiry date2023-06-16
Day's range2.2000 - 2.5500
Contract rangeN/A
Volume75
Open interest4.42k
  • Business Wire

    Pfizer Announces Positive Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Infants

    NEW YORK, August 12, 2022--Pfizer Inc. (NYSE:PFE) today announced positive top-line results from its pivotal U.S. Phase 3 study (NCT04382326) in infants evaluating its 20-valent pneumococcal conjugate vaccine candidate (20vPnC) for the prevention of invasive pneumococcal disease (IPD) caused by the 20 Streptococcus pneumoniae (pneumococcus) serotypes contained in the vaccine for the pediatric population.

  • Motley Fool

    Why Pfizer Stock Slipped Today

    What happened Shares of Pfizer (NYSE: PFE) slipped 3.3% lower as of the market close on Thursday. The decline resulted from investors' concerns about litigation related to Zantac. The U.S. Food and Drug Administration (FDA) called for the heartburn drug to be pulled from the market in 2020 due to safety concerns.

  • Yahoo Finance

    Novavax does not have a forecast for U.S. orders in 2022: CEO Erck

    Novavax missed Wall Street expectations but remains optimistic about the fourth quarter and 2023.